Lifecore Biomedical Aktie

Lifecore Biomedical für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 899376 / ISIN: US5147661046

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
18.06.2025 05:40:02

Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy

(RTTNews) - Lifecore Biomedical, Inc. (LFCR) has entered a 10-year commercial manufacturing and supply agreement with an existing partner to advance a new ophthalmic treatment through clinical stages to market readiness.

The deal reflects Lifecore's broader growth strategy focused on late-stage customer projects approaching commercialization.

CEO Paul Josephs emphasized that this long-term agreement marks a key milestone in transitioning from development to revenue-generating commercial manufacturing. In parallel, Lifecore signed a multi-million-dollar statement of work to deliver a series of fill and finish CDMO services. This includes producing various batches of the drug candidate, including Process Performance Qualification - PPQ batches, in preparation for regulatory approval and future launch.

Tuesday, LFCR rose 2.10% to close at $6.81 and slipped 1.76% after hours to end at $6.69 on the NasdaqGS.

Analysen zu Lifecore Biomedicalmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Lifecore Biomedical 6,10 -0,81% Lifecore Biomedical